PetVivo Holdings is a biomedical device company that produces medical devices and biomaterials for treating diseases in animals. Their flagship product, Spryng, is a veterinarian-administered injection used for the management of joint afflictions in dogs and horses. The company also has 17 other therapeutic devices for human and veterinary clinical applications in development.